Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3-(3,4-dimethoxyphenyl)propanoic acid is a small molecule compound classified as a short-chain fatty acid derivative. It is primarily used in research and has been shown to stimulate γ globin gene expression and erythropoiesis in vivo. This activity suggests potential utility for the treatment of β hemoglobinopathies and other anemias. The compound is also widely utilized as an intermediate in pharmaceutical synthesis (notably for drugs targeting inflammatory diseases), as a standard reference material in analytical chemistry, and for its antioxidant properties in cosmetic formulations[2][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3-(3,4-dimethoxyphenyl)propanoic acid.